Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum
- PMID: 17367402
- DOI: 10.1111/j.1748-1716.2006.01649.x
Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum
Abstract
Aims: To examine whether modulation of paracellular solute permeability affects the capability of the duodenum to adjust luminal osmolality.
Methods: Proximal duodenum was perfused with a hypotonic NaCl solution and effects on paracellular permeability to (51)Cr-EDTA, motility, anion secretion, net fluid flux and perfusate osmolality determined in anaesthetized rats in the absence and presence of the COX-2 inhibitor parecoxib. Vasoactive intestinal peptide (VIP) was used to reduce and lidocaine to augment the hypotonicity-induced increase in paracellular permeability.
Results: Luminal hypotonicity slightly increased paracellular permeability in control animals. Parecoxib induced motility, increased electrolyte and fluid secretion, potentiated the hypotonicity-induced rise in paracellular permeability and enhanced the capability to adjust luminal osmolality. VIP, given to control animals stimulated electrolyte and fluid secretion and augmented the capability to adjust luminal osmolality. Administration of VIP to parecoxib-treated animals increased secretion further, markedly reduced the hypotonicity-induced increase in permeability but did not change the osmolality-adjusting capability. Luminal lidocaine potentiated the hypotonicity-induced increase in permeability, reduced the hypotonicity-induced net fluid absorption and the osmolality-adjusting capability was 50% greater than in controls. Lidocaine, given to parecoxib-treated animals potentiated the hypotonicity-induced increase in permeability, reduced the hypotonicity-induced net fluid absorption but did not change the osmolality-adjusting capability.
Conclusions: Vasoactive intestinal peptide reduces the osmolality-adjusting capacity of the duodenum by inhibiting paracellular solute permeability but improves this capacity by stimulating active electrolyte and fluid secretion. In contrast, lidocaine improves the osmolality-adjusting capability by augmenting paracellular solute transport but depresses it by reducing the hypotonicity-induced net fluid absorption.
Similar articles
-
Products of cyclooxygenase-2 depress duodenal function in rats subjected to abdominal surgery.Acta Physiol (Oxf). 2006 Apr;186(4):279-90. doi: 10.1111/j.1748-1716.2006.01559.x. Acta Physiol (Oxf). 2006. PMID: 16634783
-
Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine.Acta Physiol (Oxf). 2006 Jan;186(1):45-58. doi: 10.1111/j.1748-1716.2005.01507.x. Acta Physiol (Oxf). 2006. PMID: 16497179
-
Hypotonicity-induced increases in duodenal mucosal permeability facilitates adjustment of luminal osmolality.Am J Physiol Gastrointest Liver Physiol. 2003 Aug;285(2):G360-70. doi: 10.1152/ajpgi.00428.2002. Epub 2003 Apr 9. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12686510
-
The impact of cyclooxygenase inhibition on duodenal motility and mucosal alkaline secretion in anaesthetized rats.Acta Physiol (Oxf). 2011 Jan;201(1):179-92. doi: 10.1111/j.1748-1716.2010.02196.x. Epub 2010 Nov 8. Acta Physiol (Oxf). 2011. PMID: 20887356 Review.
-
Duodenal mucosal protection by bicarbonate secretion and its mechanisms.J Physiol Pharmacol. 2004 Jul;55 Suppl 2:5-17. J Physiol Pharmacol. 2004. PMID: 15608357 Review.
Cited by
-
The Impact of α-Adrenoceptors in the Regulation of the Hypotonicity-Induced Increase in Duodenal Mucosal Permeability In Vivo.Pharmaceutics. 2021 Dec 6;13(12):2096. doi: 10.3390/pharmaceutics13122096. Pharmaceutics. 2021. PMID: 34959377 Free PMC article.
-
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.Acta Pharm Sin B. 2021 Jun;11(6):1667-1675. doi: 10.1016/j.apsb.2020.12.019. Epub 2021 Jan 5. Acta Pharm Sin B. 2021. PMID: 34221875 Free PMC article.
-
The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):90-100. doi: 10.1038/nrgastro.2012.221. Epub 2012 Nov 20. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23165236 Review.
-
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies.Front Pharmacol. 2021 May 4;12:681417. doi: 10.3389/fphar.2021.681417. eCollection 2021. Front Pharmacol. 2021. PMID: 34017262 Free PMC article. Review.
-
Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation.Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):248-54. doi: 10.1016/j.ijrobp.2011.02.004. Epub 2011 Apr 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 21489707 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials